- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 7, 2025 | 35.6M sh |
| Long Term Debt | Q2 2025 · Mar 29, 2025 | $1.99B |
| Long Term Debt | Q2 2025 · Sep 28, 2024 | $0 |
| Cash And Equivalents | Q2 2025 · Mar 29, 2025 | $282M |
| Cash And Equivalents | Q2 2025 · Sep 28, 2024 | $230M |
| Stockholders Equity | Q2 2025 · Mar 29, 2025 | $1.09B |
| Stockholders Equity | Q2 2025 · Dec 28, 2024 | $1.11B |
| Stockholders Equity | Q2 2025 · Sep 28, 2024 | $2.14B |
| Stockholders Equity | Q2 2025 · Mar 30, 2024 | $2.43B |
| Stockholders Equity | Q2 2025 · Dec 30, 2023 | $2.42B |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $2.39B |
| Current Liabilities | Q2 2025 · Mar 29, 2025 | $596M |
| Current Liabilities | Q2 2025 · Sep 28, 2024 | $457M |
| Total Liabilities | Q2 2025 · Mar 29, 2025 | $2.97B |
| Total Liabilities | Q2 2025 · Sep 28, 2024 | $668M |
| Current Assets | Q2 2025 · Mar 29, 2025 | $1.43B |
| Current Assets | Q2 2025 · Sep 28, 2024 | $886M |
| Total Assets | Q2 2025 · Mar 29, 2025 | $4.06B |
| Total Assets | Q2 2025 · Sep 28, 2024 | $2.81B |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 31.8M sh |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 31.8M sh |
| Capex | Q2 2025 · Mar 30, 2024 | $41M |
| Operating Cash Flow | Q2 2025 · Mar 30, 2024 | −$7M |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $0.44 |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $0.19 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $0.44 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $0.19 |
| Sga Expense | Q2 2025 · Mar 30, 2024 | $28M |
| Sga Expense | Q2 2025 · Mar 30, 2024 | $56M |
| Net Income | Q2 2025 · Mar 30, 2024 | $14M |
| Net Income | Q2 2025 · Mar 30, 2024 | $6M |
| Operating Income | Q2 2025 · Mar 30, 2024 | $21M |
| Operating Income | Q2 2025 · Mar 30, 2024 | $9M |
| Cost Of Revenue | Q2 2025 · Mar 30, 2024 | $488M |
| Cost Of Revenue | Q2 2025 · Mar 30, 2024 | $965M |